NO996484L - Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner - Google Patents

Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner

Info

Publication number
NO996484L
NO996484L NO996484A NO996484A NO996484L NO 996484 L NO996484 L NO 996484L NO 996484 A NO996484 A NO 996484A NO 996484 A NO996484 A NO 996484A NO 996484 L NO996484 L NO 996484L
Authority
NO
Norway
Prior art keywords
dispersions
new process
preparing solid
solid paroxetine
paroxetine
Prior art date
Application number
NO996484A
Other languages
English (en)
Other versions
NO996484D0 (no
Inventor
Philip J Krape
Sou-Chan Chang
Ii William A Hein
Christopher A Teleha
Original Assignee
Endo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Inc filed Critical Endo Pharmaceuticals Inc
Publication of NO996484D0 publication Critical patent/NO996484D0/no
Publication of NO996484L publication Critical patent/NO996484L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO996484A 1997-06-30 1999-12-27 Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner NO996484L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/885,068 US5955475A (en) 1997-06-30 1997-06-30 Process for manufacturing paroxetine solid dispersions
PCT/US1998/013350 WO1999000131A1 (en) 1997-06-30 1998-06-26 Novel process for manufacturing paroxetine solid dispersions

Publications (2)

Publication Number Publication Date
NO996484D0 NO996484D0 (no) 1999-12-27
NO996484L true NO996484L (no) 2000-02-25

Family

ID=25386061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996484A NO996484L (no) 1997-06-30 1999-12-27 Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner

Country Status (23)

Country Link
US (1) US5955475A (no)
EP (1) EP0991408B1 (no)
JP (1) JP2002514227A (no)
KR (1) KR100571044B1 (no)
CN (1) CN1121219C (no)
AP (1) AP9901725A0 (no)
AR (1) AR013131A1 (no)
AT (1) ATE290381T1 (no)
AU (1) AU733194B2 (no)
BR (1) BR9810231A (no)
CA (1) CA2295752C (no)
DE (1) DE69829286T2 (no)
ES (1) ES2239395T3 (no)
HK (1) HK1029529A1 (no)
MA (1) MA24589A1 (no)
NO (1) NO996484L (no)
NZ (1) NZ502062A (no)
OA (1) OA11518A (no)
RU (1) RU2185820C2 (no)
SA (1) SA98190227A (no)
TR (1) TR199903315T2 (no)
WO (1) WO1999000131A1 (no)
ZA (1) ZA985488B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
DK0994872T3 (da) * 1997-06-10 2001-05-28 Synthon Bv 4-phenylpiperidin-forbindelser
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
DE50011819D1 (de) * 1999-03-12 2006-01-12 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6503927B1 (en) * 1999-10-28 2003-01-07 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
DE60028754T2 (de) * 1999-11-12 2007-05-31 Abbott Laboratories, Abbott Park Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
DE10000792A1 (de) * 2000-01-11 2001-07-19 Bernhard C Lippold Formulierungen von Wirkstoffen in Form einer festen Dispersion
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
WO2001066091A1 (en) * 2000-03-09 2001-09-13 Astrazeneca Ab Method of preparing solid dispersions
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
WO2002045509A1 (en) * 2000-12-07 2002-06-13 College Of Pharmacy A novel anti-fertility agent
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
WO2002085360A1 (en) * 2001-04-25 2002-10-31 Pentech Pharmaceuticals, Inc. Optimized procedures for the manufacture of paroxetine salts
EP1401399A2 (en) * 2001-06-22 2004-03-31 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
WO2003000292A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers
WO2003020717A1 (en) * 2001-08-02 2003-03-13 Spurcourt Limited Paroxetine isethionate salt, process of preparation and use in the treatment of depression
CA2471715A1 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
KR100691608B1 (ko) * 2005-02-21 2007-03-12 (주)나노하이브리드 염기성 고분자가 첨가된 유리 염기형 약물과 층상형 규산염의 하이브리드 및 그의 제조방법
JP5153629B2 (ja) * 2005-08-02 2013-02-27 ルピン・リミテッド 選択的セロトニン再取り込み阻害剤の新規の制御放出組成物
US20070112031A1 (en) * 2005-11-14 2007-05-17 Gant Thomas G Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
EP2112925A4 (en) * 2006-11-15 2013-01-09 Abbott Lab SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
KR100954828B1 (ko) 2006-12-22 2010-04-27 주식회사유한양행 레바프라잔 함유 고체분산체 및 그의 제조방법
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
JP5700367B2 (ja) * 2010-05-06 2015-04-15 高田製薬株式会社 パロキセチン含有フイルムコ−テイング経口製剤
EP2649989B1 (en) 2012-04-13 2017-10-18 King Saud University Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
WO2014009970A2 (en) * 2012-07-09 2014-01-16 Hetero Research Foundation Linagliptin solid dispersion
US9381199B2 (en) 2012-07-09 2016-07-05 Hetero Research Foundation Linagliptin solid dispersion
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
WO2018127088A1 (en) * 2017-01-06 2018-07-12 Sunshine Lake Pharma Co., Ltd. Lurasidone solid dispersion and preparation method thereof
RU2698400C1 (ru) * 2018-12-17 2019-08-26 Георгий Сергеевич Немов Способ лечения депрессии у собак и кошек

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5147733B2 (no) * 1974-02-15 1976-12-16
US4933360A (en) * 1983-03-16 1990-06-12 Boehringer Ingelheim Pharmaceuticals, Inc. Novel chlorthalidone process and product
DD220225A5 (de) * 1983-03-16 1985-03-27 Boehringer Ingelheim Ltd Verfahren zur herstellung einer festkoerperdispersion von chlorthalidon
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
DK0580860T4 (da) * 1991-04-16 2005-03-21 Nippon Shinyaku Co Ltd Fremgangsmåde til fremstilling af en fast dispersion
WO1993011749A1 (en) * 1991-12-18 1993-06-24 Warner-Lambert Company A process for the preparation of a solid dispersion
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
WO1999000131A1 (en) 1999-01-07
ATE290381T1 (de) 2005-03-15
EP0991408A1 (en) 2000-04-12
HK1029529A1 (en) 2001-04-06
JP2002514227A (ja) 2002-05-14
CA2295752A1 (en) 1999-01-07
AU733194B2 (en) 2001-05-10
KR100571044B1 (ko) 2006-04-13
EP0991408A4 (en) 2003-07-09
NO996484D0 (no) 1999-12-27
RU2185820C2 (ru) 2002-07-27
SA98190227A (ar) 2005-12-03
MA24589A1 (fr) 1998-12-31
CN1265593A (zh) 2000-09-06
CA2295752C (en) 2004-10-26
KR20010020592A (ko) 2001-03-15
BR9810231A (pt) 2000-08-08
EP0991408B1 (en) 2005-03-09
DE69829286T2 (de) 2006-01-12
TR199903315T2 (xx) 2000-09-21
NZ502062A (en) 2001-10-26
ES2239395T3 (es) 2005-09-16
US5955475A (en) 1999-09-21
OA11518A (en) 2004-02-04
CN1121219C (zh) 2003-09-17
AP9901725A0 (en) 1999-12-31
ZA985488B (en) 1999-04-22
AU8171798A (en) 1999-01-19
AR013131A1 (es) 2000-12-13
DE69829286D1 (de) 2005-04-14

Similar Documents

Publication Publication Date Title
NO996484L (no) Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner
EE9900488A (et) Farmakoloogiliselt aktiivse aine valmistamise uus meetod
NO20012162D0 (no) Fremgangsmåte til klargjöring av en brönnboring
HK1031382A1 (en) Spiroazabicyclic heterocyclic compounds, a method for producing the same and use thereof
FI974139A (fi) Menetelmä selluloosan modifioimiseksi
NO994717D0 (no) FremgangsmÕte og maskin for fremstilling av fleraksiale fiberduker
NO970939L (no) Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
FI971620A0 (fi) Autentikointimenetelmä
ID28489A (id) Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
FI103894B1 (fi) Menetelmä onttopolymeeripartikkelilateksin valmistamiseksi
DE69800225D1 (de) Kapselmaschine
PL344390A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
HUP0003268A3 (en) Method for preparing a bitumen emulsion, resulting bitumen emulsion, use thereof
NO995097D0 (no) Fremgangsmåte for fremstilling av en asfaltsammensetning
NO20003625L (no) Ny fremgangsmÕte for fremstilling av et ketimin
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
HUP0001751A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
NO20010629D0 (no) Fremgangsmåte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid
GB9803881D0 (en) Process for preparing a bitumen emulsion
NO306097B1 (no) Fremgangsmåte for fremstilling av en kölle
NO20001793D0 (no) Fremgangsmåte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
IS5523A (is) Aðferð til að framleiða ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amín

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application